Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deng-Fu Yao

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
World Journal of Gastroenterology|August 30, 2005
Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinomaZhi-Jian Yu, Jia-Wei Yu, Wei Cai, et al.
World Journal of Gastroenterology|August 12, 2005
Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinomaZhi-Zhen Dong, Deng-Fu Yao, Deng-Bing Yao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 17, 2013
[Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis]Dan-dan Yu, Min Yao, Jie Chen, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|August 4, 2010
[Expression characteristics of hypoxia inducible factor-1a and its clinical values in hepatocellular carcinoma]Zhi-zhen Dong, Deng-fu Yao, Shan-shan Li, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 12, 2009
Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinomaDeng-Fu Yao, Hua Jiang, Min Yao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 13, 2010
Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in ratsZhi-Zhen Dong, Deng-Fu Yao, Wei Wu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 14, 2009
Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesisWei Wu, Deng-Fu Yao, Li-Wei Qiu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 6, 2013
Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinomaMin Yao, Deng-Fu Yao, Yin-Zhu Bian, et al.
Molecular and Clinical Oncology|June 8, 2017
Cancer survival in Qidong between 1972 and 2011: A population-based analysisJian-Guo Chen, Jian Zhu, Yong-Hui Zhang, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
World Journal of Gastroenterology|August 30, 2005
Evaluation of HCPTd1,d14-double passaged intervening chemotherapy protocol for hepatocellular carcinomaZhi-Jian Yu, Jia-Wei Yu, Wei Cai, et al.
World Journal of Gastroenterology|August 12, 2005
Expression and alteration of insulin-like growth factor II-messenger RNA in hepatoma tissues and peripheral blood of patients with hepatocellular carcinomaZhi-Zhen Dong, Deng-Fu Yao, Deng-Bing Yao, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|September 17, 2013
[Short hairpin RNA mediated glypican-3 silencing inhibits hepatoma cell invasiveness and disrupts molecular pathways of angiogenesis]Dan-dan Yu, Min Yao, Jie Chen, et al.
Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology|August 4, 2010
[Expression characteristics of hypoxia inducible factor-1a and its clinical values in hepatocellular carcinoma]Zhi-zhen Dong, Deng-fu Yao, Shan-shan Li, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 12, 2009
Quantitative analysis of hepatic hypoxia-inducible factor-1alpha and its abnormal gene expression during the formation of hepatocellular carcinomaDeng-Fu Yao, Hua Jiang, Min Yao, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 13, 2010
Delayed hepatocarcinogenesis through antiangiogenic intervention in the nuclear factor-kappa B activation pathway in ratsZhi-Zhen Dong, Deng-Fu Yao, Wei Wu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|October 14, 2009
Characteristics of hepatic nuclear-transcription factor-kappa B expression and quantitative analysis in rat hepatocarcinogenesisWei Wu, Deng-Fu Yao, Li-Wei Qiu, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|April 6, 2013
Values of circulating GPC-3 mRNA and alpha-fetoprotein in detecting patients with hepatocellular carcinomaMin Yao, Deng-Fu Yao, Yin-Zhu Bian, et al.
Molecular and Clinical Oncology|June 8, 2017
Cancer survival in Qidong between 1972 and 2011: A population-based analysisJian-Guo Chen, Jian Zhu, Yong-Hui Zhang, et al.
Pageof 6